AstraZeneca plans direct listing on New York Stock Exchange but isn’t quitting London – The Guardian
- AstraZeneca plans direct listing on New York Stock Exchange but isn’t quitting London The Guardian
- AstraZeneca to elevate New York listing in blow to London Financial Times
- ‘Knock-back for London’ as AstraZeneca sells shares directly on rival New York Stock Exchange Sky News
- AstraZeneca plans full US listing, but defuses fears of UK exit Reuters
- AstraZeneca to overhaul US listing but remain on London market and keep UK HQ The Independent